Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 3 |
2018 | 2 |
2020 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Myocyte-Damaging Effects and Binding Kinetics of Boronic Acid and Epoxyketone Proteasomal-Targeted Drugs.
Cardiovasc Toxicol. 2018 Dec;18(6):557-568. doi: 10.1007/s12012-018-9468-9.
Cardiovasc Toxicol. 2018.
PMID: 29951728
Mechanisms of the Cardiac Myocyte-Damaging Effects of Dasatinib.
Hasinoff BB, Patel D.
Hasinoff BB, et al.
Cardiovasc Toxicol. 2020 Aug;20(4):380-389. doi: 10.1007/s12012-020-09565-7.
Cardiovasc Toxicol. 2020.
PMID: 32124237
Item in Clipboard
Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib.
Hasinoff BB, Patel D, Wu X.
Hasinoff BB, et al.
Cardiovasc Toxicol. 2017 Jul;17(3):237-250. doi: 10.1007/s12012-016-9378-7.
Cardiovasc Toxicol. 2017.
PMID: 27388042
Item in Clipboard
Progress curve analysis of the kinetics of slow-binding anticancer drug inhibitors of the 20S proteasome.
Hasinoff BB.
Hasinoff BB.
Arch Biochem Biophys. 2018 Feb 1;639:52-58. doi: 10.1016/j.abb.2017.12.020. Epub 2018 Jan 2.
Arch Biochem Biophys. 2018.
PMID: 29305052
Item in Clipboard
Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity.
Hasinoff BB, Patel D.
Hasinoff BB, et al.
Arch Biochem Biophys. 2017 Nov 1;633:23-28. doi: 10.1016/j.abb.2017.09.003. Epub 2017 Sep 5.
Arch Biochem Biophys. 2017.
PMID: 28887129
Item in Clipboard
The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent Dexrazoxane.
Hasinoff BB, Patel D, Wu X.
Hasinoff BB, et al.
Cardiovasc Toxicol. 2020 Jun;20(3):312-320. doi: 10.1007/s12012-019-09554-5.
Cardiovasc Toxicol. 2020.
PMID: 31773441
Item in Clipboard
The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with Specificity.
Hasinoff BB, Patel D, Wu X.
Hasinoff BB, et al.
Cardiovasc Toxicol. 2017 Jul;17(3):297-306. doi: 10.1007/s12012-016-9386-7.
Cardiovasc Toxicol. 2017.
PMID: 27696211
Item in Clipboard
Cite
Cite